Bradley D Stein1, Brendan Saloner2, Rose Kerber3, Mark Sorbero4, Adam J Gordon5. 1. RAND Corporation, Pittsburgh, PA. Electronic address: stein@rand.org. 2. Department of Health Policy and Management, Johns Hopkins University, Baltimore MD. 3. Boston, MA. 4. RAND Corporation, Pittsburgh, PA. 5. Program for Addiction Research, Knowledge, and Advocacy, University of Utah School of Medicine, and VA Salt Lake City Health Care System, Salt Lake City, UT.
Abstract
STUDY OBJECTIVE: Buprenorphine treatment for opioid use disorder provided in the emergency department with subsequent buprenorphine treatment by community prescribers is associated with improved outcomes, but the frequency with which this occurs is unknown. We examined the rates of subsequent buprenorphine treatment for buprenorphine-naïve individuals filling buprenorphine prescriptions from emergency physicians and initiated buprenorphine treatment and how such rates varied before and during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Using pharmacy claims capturing an estimated 92% of prescriptions filled at US retail pharmacies, we identified buprenorphine prescriptions filled between February 1, 2019, and November 30, 2020, written by emergency physicians. In this observational study, we calculated the rate at which patients subsequently filled buprenorphine prescriptions from other nonemergency clinicians, the frequency with which subsequent filled prescriptions were from different types of prescribers, and the changes in the rates of subsequent prescriptions following the declaration of the COVID-19 public health emergency. RESULTS: We identified 22,846 prescriptions written by emergency physicians and filled by buprenorphine-naïve patients. They were most commonly paid for by Medicaid and were in metropolitan counties; 28.5% of patients subsequently filled buprenorphine prescriptions written by other clinicians. Adult primary care physicians and advanced practice providers (eg, physician assistants and nurse practitioners) were responsible for most of the subsequent prescriptions. The rates of subsequent prescriptions were 3.5% lower after the COVID-19 public health emergency declaration. CONCLUSION: The majority of patients filling buprenorphine prescriptions written by emergency physicians do not subsequently fill prescriptions written by other clinicians, and the rates of subsequent prescriptions were lower after the declaration of the COVID-19 public health emergency. These findings highlight the need for a system of care that improves buprenorphine treatment continuity of care for patients with opioid use disorder from emergency settings to community treatment providers.
STUDY OBJECTIVE: Buprenorphine treatment for opioid use disorder provided in the emergency department with subsequent buprenorphine treatment by community prescribers is associated with improved outcomes, but the frequency with which this occurs is unknown. We examined the rates of subsequent buprenorphine treatment for buprenorphine-naïve individuals filling buprenorphine prescriptions from emergency physicians and initiated buprenorphine treatment and how such rates varied before and during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Using pharmacy claims capturing an estimated 92% of prescriptions filled at US retail pharmacies, we identified buprenorphine prescriptions filled between February 1, 2019, and November 30, 2020, written by emergency physicians. In this observational study, we calculated the rate at which patients subsequently filled buprenorphine prescriptions from other nonemergency clinicians, the frequency with which subsequent filled prescriptions were from different types of prescribers, and the changes in the rates of subsequent prescriptions following the declaration of the COVID-19 public health emergency. RESULTS: We identified 22,846 prescriptions written by emergency physicians and filled by buprenorphine-naïve patients. They were most commonly paid for by Medicaid and were in metropolitan counties; 28.5% of patients subsequently filled buprenorphine prescriptions written by other clinicians. Adult primary care physicians and advanced practice providers (eg, physician assistants and nurse practitioners) were responsible for most of the subsequent prescriptions. The rates of subsequent prescriptions were 3.5% lower after the COVID-19 public health emergency declaration. CONCLUSION: The majority of patients filling buprenorphine prescriptions written by emergency physicians do not subsequently fill prescriptions written by other clinicians, and the rates of subsequent prescriptions were lower after the declaration of the COVID-19 public health emergency. These findings highlight the need for a system of care that improves buprenorphine treatment continuity of care for patients with opioid use disorder from emergency settings to community treatment providers.
Authors: Gail D'Onofrio; Marek C Chawarski; Patrick G O'Connor; Michael V Pantalon; Susan H Busch; Patricia H Owens; Kathryn Hawk; Steven L Bernstein; David A Fiellin Journal: J Gen Intern Med Date: 2017-02-13 Impact factor: 5.128
Authors: Alexander M Ponizovsky; Anatoly Margolis; Ludmila Heled; Paula Rosca; Irena Radomislensky; Alexander Grinshpoon Journal: Subst Use Misuse Date: 2010 Impact factor: 2.164
Authors: Kathryn Hawk; Jason Hoppe; Eric Ketcham; Alexis LaPietra; Aimee Moulin; Lewis Nelson; Evan Schwarz; Sam Shahid; Donald Stader; Michael P Wilson; Gail D'Onofrio Journal: Ann Emerg Med Date: 2021-06-22 Impact factor: 5.721
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Kristin M Holland; Christopher Jones; Alana M Vivolo-Kantor; Nimi Idaikkadar; Marissa Zwald; Brooke Hoots; Ellen Yard; Ashley D'Inverno; Elizabeth Swedo; May S Chen; Emiko Petrosky; Amy Board; Pedro Martinez; Deborah M Stone; Royal Law; Michael A Coletta; Jennifer Adjemian; Craig Thomas; Richard W Puddy; Georgina Peacock; Nicole F Dowling; Debra Houry Journal: JAMA Psychiatry Date: 2021-04-01 Impact factor: 21.596
Authors: Barbara Andraka-Christou; Kathryn Bouskill; Rebecca L Haffajee; Olivia Randall-Kosich; Matthew Golan; Rachel Totaram; Adam J Gordon; Bradley D Stein Journal: Am J Drug Alcohol Abuse Date: 2021-04-28 Impact factor: 3.912
Authors: Jake R Morgan; Bruce R Schackman; Zoe M Weinstein; Alexander Y Walley; Benjamin P Linas Journal: Drug Alcohol Depend Date: 2019-05-03 Impact factor: 4.852